NewAmsterdam Pharma Company N.V. (NAMS)

Healthcare · Biotechnology · NASDAQ

NewAmsterdam Pharma Company N.V. (NAMS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $3.27B and a free-cash-flow yield of -4.6%. Over the most recent reported fiscal year, revenue declined 50.6%.

Market cap	$3.27B
Trailing P/E	—
FCF yield	-4.6%
Revenue growth (YoY)	-50.6%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live NAMS data on Nama Insights →